Could Milan be the new home for the EMA?
Wayne Pines, President of Healthcare at APCO Worldwide in Washington DC and a former Associate Commissioner of the FDA believes Milan is a logical choice for the relocation of the EMA...
List view / Grid view
News
Mn-PyC3A MRI contrast agent may be a safer alternative to gadolinium
Researchers have developed a potential alternative to gadolinium-based contrast agents for magnetic resonance imaging...
Scientists reverse diabetes using modified blood stem cells
Researchers have successfully reversed type 1 diabetes by infusing blood stem cells pre-treated to produce more PD-L1...
Molecular pathway offers treatment targets for pulmonary fibrosis
A study has identified a molecular pathway that appears to be critical to the development of fibrosis...
Engineering the gut microbiome may help treat Crohn’s disease
Researchers have singled out a bacterial enzyme behind an imbalance in the gut microbiome linked to Crohn's disease...
Proteome of the human heart mapped for the first time
Researchers have compiled an atlas of the heart to identify differences between healthy and diseased cells...
ARBs may solve the global antibiotic crisis by 2020
A British biopharmaceuticals company, have developed Antibiotic Resistance Breakers which can restore the original potency against both Gram-positive and Gram-negative bacteria...
pIC found to prevent the development of liver cancer
A synthetic double-stranded RNA has potential for use as an anti-liver cancer vaccine...
CRISPR-carrying nanoparticles edit the genome
New delivery system deletes disease-causing genes and reduces cholesterol...
Next-generation optogenetic molecules control single neurons
Focused laser beam could help scientists map connections among neurons that underlie behaviour...
Synthetic T-cells engineered to combat cancer
Researchers have engineered T-cells in the laboratory to combat tumours...
CRISPR-dCas9 reveals surprising insight into breast cancer development
Changing the epigenetic code of a single gene is enough to cause a healthy breast cell to become abnormal...
VEGF found to prolong survival of stem cells
A team of researchers have developed a new technology, which is promising to understand and treat ischemic diseases...
Exclusive speaker interview with Professor Nagy Habib – MiNA Therapeutics/Imperial College London
SMi are delighted to have, Nagy Habib, Head of HPB Surgery, Imperial College London and Co-Founder, MiNA Therapeutics, as the Keynote Address for day 1 at RNA Therapeutics 2018!
Ancient antiviral response could help treat cancer
By stimulating a patient’s immune system, a drug already in use to treat a blood disorder can prevent the growth of a variety of solid tumours...